{
    "clinical_study": {
        "@rank": "90731", 
        "arm_group": [
            {
                "arm_group_label": "Vantris", 
                "description": "Patient who categorized as who underwent endoscopic correction procedure, were patients who under general anesthesia performed by a single experienced surgeon using a 10Fr Storz\u00ae cystoscope with PPC (Vantris\u00ae) subureteral or intraureteral injection, or a combination of both techniques, depending on the anatomy of the ureteral meatus and VUR grade."
            }, 
            {
                "arm_group_label": "Cohen reimplantation", 
                "description": "Patient underwent surgical management were all had ureteral re-implatation with Cohen technique done by single experienced pediatric urologist."
            }, 
            {
                "arm_group_label": "Continuous Antibiotic Prophylaxis", 
                "description": "Group of patient treated with conservative management were children treated with culture guided antibiotics and maintained on 1st or 2nd generation cephalosporin as continuous antibiotic prophylaxis until time of 1 year follow-up."
            }
        ], 
        "brief_summary": {
            "textblock": "Endoscopic correction of VUR has gained its popularity due to its less invasiveness,\n      associated low morbidity and short hospital stay. Although short term follow-up had\n      justified their efficacy; however, long term recurrence and complications following\n      endoscopic correction were also being reported in the literatures (6). Currently, there are\n      insufficient evidences on the efficacy and safety of biocompatible tissue augmenting\n      materials used for endoscopic correction of VUR; particularly on the new tissue bulking\n      agents. (6)  Polyacrylate polyalcohol copolymer (PPC)-Vantris \u00ae (Promedon, Cordoba,\n      Argentina) is the newest tissue augmenting biocompatible Acrylics used for endoscopic\n      correction of VUR."
        }, 
        "brief_title": "Polyacrylate Polyalcohol Copolymer for Vesicoureteral Reflux", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Vesicoureteral Reflux (VUR)", 
            "Urinary Tract Infection"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gastroesophageal Reflux", 
                "Urinary Tract Infections", 
                "Vesico-Ureteral Reflux"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Included patients for the study were only those who had 1- 3months and >1year\n             post-treatment follow-up study with voiding cystourethrogram (VCUG), kidney\n             ultrasound, dimercaptosuccinic acid(DMSA) renal scan, and urine culture.\n\n        Exclusion Criteria:\n\n          -  Excluded cases were patients who had VUR grade 1 and grade 5, no complete follow-up\n             work ups, concomitant neurogenic bladder, anatomical malformation of the urinary\n             tract (obstruction, complete duplicated pelvocaliceal system), previous surgical or\n             endoscopic procedures, and suspected or confirmed dysfunctional voiding by clinical\n             findings or abnormal results (irregular bladder wall, diverticulum) on VCUG or\n             urodynamic study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "1 Year", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "children diagnosed with primary VUR grade 2-4 from 2006-2012 treated by a single urologist\n        with different treatment modalities- conservative continuous antibiotic prophylaxis,\n        endoscopic correction with PPC and open ureteral re-implantation with Cohen technique."
            }
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926353", 
            "org_study_id": "SLMC13-100"
        }, 
        "intervention_browse": {
            "mesh_term": "Anti-Bacterial Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vesicoureteral Reflux (VUR)", 
            "Complicated Urinary Tract Infection", 
            "Vantris", 
            "Polyacrylate Polyalcohol Copolymer"
        ], 
        "lastchanged_date": "August 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Quezon City", 
                    "country": "Philippines", 
                    "state": "NCR", 
                    "zip": "1102"
                }, 
                "name": "St. Luke's Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Philippines"
        }, 
        "number_of_groups": "3", 
        "official_title": "Tissue Bulking Agent -Polyacrylate Polyalcohol Copolymer for Endoscopic Correction of Vesicoureteral Reflux in Children: A Comparative Study", 
        "overall_official": {
            "affiliation": "Institute of Urology, St. Luke's Medical Center, Quezon City, Philippines", 
            "last_name": "Marcelino L Morales, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Philippines: Department of Health", 
                "Philippines: Ethics Committee", 
                "Philippines: Philippine Council for Health Research and Development"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Rate of complete resolution of VUR on follow-up VCUG at 3 months and 1 year.", 
            "measure": "Rate of Treatment success", 
            "safety_issue": "Yes", 
            "time_frame": "3 months, 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926353"
        }, 
        "responsible_party": {
            "investigator_affiliation": "St. Luke's Medical Center, Philippines", 
            "investigator_full_name": "Michael E. Chua", 
            "investigator_title": "Urology Staff", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The rate of Renal scarring is defined as consistent decreased tracer activity noted in follow-up DMSA scan.", 
                "measure": "Rate of renal scar development", 
                "safety_issue": "Yes", 
                "time_frame": "at 3 months, 1 year"
            }, 
            {
                "description": "Number of hospital days incurred related to VUR treatment, such as hospital admission on treatment period, recovery period, and subsequent admissions for complicated UTI secondary to VUR.", 
                "measure": "Length of VUR treatment related hospital stay", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Rate of VUR with resoultion noted on 3 month follow-up; however, VUR noted on 1 year VCUG follow-up. Failed treatment defined as persistent VUR or VUR grade progressed despite treatment.", 
                "measure": "Rate of failed treatment response", 
                "safety_issue": "Yes", 
                "time_frame": "3 months, 1 year"
            }
        ], 
        "source": "St. Luke's Medical Center, Philippines", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Luke's Medical Center, Philippines", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}